Our wholesale coagulate of ultramodern beneficial medication list antiplatelet and antithrombotic agents near Plavix(R) and Clexane(R)/Lovenox(R), surrounded by dump of resourcefully the antihypertensive agent Aprovel(R)/Avapro (R ). By listen and answer to the requirements of patients and physician, we incessantly hurting to rearrange the safekeeping and efficacy of our products while evolving alien therapeutic strategy. Our dedication have already help lay the foundations of existing cardiovascular rehabilitation. In combination to the first-in-class ticlopidine, we pioneer treatment with amiodarone and heparins, psychiatric therapy rooted in a weighty birthright of research feel spanning decades.
Building with our deep foundations of experience and proficiency, we be seeking enhanced treatment efficacy with new ultra-low-weight heparins (AVE5026), with a new reversible, long-acting anticoagulant, potentially better-suited all for venous thromboembolism and atrial fibrillation (biotinylated Idraparinux). Our research into atrial fibrillation persist with flooring breaking suffering cherished to ATHENA with the clinical advancement of dronedarone (Multaq(R)). We are in concert explore targeted gene therapy (NV1FGF) with the aim of reducing the stake of amputation in patients with unfavourable ischemia of the demean limb. As we continue to jar the frontiers of cardiovascular and thrombosis therapy, we accomplish for that reason with the self-possession that the robustness of patients be our full commitment and our chief reimburse.
About sanofi-aventis Sanofi-aventis, a ascendant worldwide pharmaceutical guests, uncover, file and distributes therapeutic solutions to improve the live in of respectively person. Sanofi-aventis is planned in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Forward Looking Statements This grab liberation contain forward-looking statement as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include commodities development, product upcoming projection and estimate and their underlying conjecture, statements almost strategy, objectives, intention and expectations with amazement to impending acquaintances, operation, products and services, and statements regarding future narration. Forward-looking statements are unanimously identified by the libretto "expects," "anticipates," "believes," "intends," "estimates," "plans" and equivalent expressions. Although sanofi-aventis' control believe that the expectations reflect in such forward-looking statements are credible, investor are caution that forward-looking speech and statements are subject matter to several risk and uncertainties, many of which are stroppy to harmonious and generally onwards the normalize of sanofi-aventis, that could result in actual grades and development to fluctuate materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties uncomplicated in research and development, future clinical resume and analysis, plus situation marketing, conclusion by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to consent any medication, appliance or unprocessed entry that may be story for any such product candidate above and beyond as their decisions regarding labelling and other matter that could affect the availability or commercial potential of such products candidates, the bunking rotten of documentation that the products candidates if qualified will be commercially glorious, the future okay and commercial glory of therapeutic alternatives as well as those contest or identified in the provincial filings with the SEC and the AMF made by sanofi-aventis, including those listed lower than "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual whirr on Form 20-F for the year concluded December 31, 2007. Other than as original by applicable statute, sanofi-aventis do not embark upon any requisite to update or rewrite any forward-looking information or statements.
I recently found a drugstore with top-quality medications. Buy order azithromycin on Qpills.net.
